Literature DB >> 28121699

Health Physics Aspects of Neutron Activated Components in a Linear Accelerator.

Shuntong Guo1, Paul L Ziemer.   

Abstract

The purpose of this study was to investigate the residual radioactivity in the therapy accessories of a medical x ray linear accelerator. The residual radioactivity mainly originated from nuclear activation reactions by neutrons, which are present as a contamination radiation in the x-ray beam. The radiation used in this study was the 25 MV x-ray beam produced by a CGR Saturne III linear accelerator. The five treatment aids include four wedges of various angles and one cerrobend block. The decrease in dose rates with time was followed for 60 min for each of the five treatment aids immediately after 999 monitor units of irradiation. The integral doses from the surface of each of four activated therapy accessories following three different radiation doses were measured by using thermoluminescent dosimeters (CaF2). In the TLD measurement, polyethylene filters were used to differentiate β or β particles from the mixed decay radiation. A high-purity germanium detection system was utilized to collect and to analyze the γ spectra from the activated therapy accessories. The residual radioisotopes found in the 15° wedge and 30° wedge included V, Cr, Cr, Mn, Fe, Co, and Ni. In the 45° and 60° wedges, the radionuclides identified were Co, Ni, Cu, and W. The principal nuclides identified in the irradiated cerrobend block were In, Sn, Cd, Pb. The corresponding nuclear reactions from which the residual radionuclides produced were confirmed by consulting the current literature.

Entities:  

Year:  2004        PMID: 28121699

Source DB:  PubMed          Journal:  Health Phys        ISSN: 0017-9078            Impact factor:   1.316


  1 in total

1.  Design and fabrication of a Nano-based neutron shield for fast neutrons from medical linear accelerators in radiation therapy.

Authors:  Younes Afkham; Asghar Mesbahi; Abdolali Alemi; Farhad Zolfagharpour; Nasrollah Jabbari
Journal:  Radiat Oncol       Date:  2020-05-11       Impact factor: 3.481

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.